Paper36938678
LINC00460 Facilitates Cell Proliferation and Inhibits Ferroptosis in Breast Cancer Through the miR-320a/MAL2 Axis.
Zhang C and 5 others. Technol Cancer Res Treat, 2023. Cited by 22 papers, by iCite.
Cite this record
ConductScience Library. LINC00460 Facilitates Cell Proliferation and Inhibits Ferroptosis in Breast Cancer Through the miR-320a/MAL2 Axis. Papers, record 36938678. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36938678
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- LINC00460 Facilitates Cell Proliferation and Inhibits Ferroptosis in Breast Cancer Through the miR-320a/MAL2 Axis.
- PubMed
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Breast Neoplasms | Major topic |
| Ferroptosis | Major topic |
| MicroRNAs | Major topic |
| RNA, Long Noncoding | Major topic |
| Female | |
| Humans | |
| Cell Line, Tumor | |
| Cell Proliferation | |
| Gene Expression Regulation, Neoplastic | |
| Myelin and Lymphocyte-Associated Proteolipid Proteins | |
| Up-Regulation |
Source PubMed
References39
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 28428107 | Clinicopathological factors associated with survival in patients with breast cancer brain metastasis. | Hum Pathol | 2017 | https://conductscience.org/library/papers/28428107 | PubMed |
| 2 | 33526059 | LINC00460/DHX9/IGF2BP2 complex promotes colorectal cancer proliferation and metastasis by mediating HMGA1 mRNA stability depending on m6A modification. | J Exp Clin Cancer Res | 2021 | https://conductscience.org/library/papers/33526059 | PubMed |
| 3 | 31786194 | Mechanisms of lncRNA/microRNA interactions in angiogenesis. | Life Sci | 2020 | https://conductscience.org/library/papers/31786194 | PubMed |
| 4 | 31364108 | Downregulated LINC00460 inhibits cell proliferation and promotes cell apoptosis in prostate cancer. | Eur Rev Med Pharmacol Sci | 2019 | https://conductscience.org/library/papers/31364108 | PubMed |
| 5 | 33251049 | LINC00460-miR-149-5p/miR-150-5p-Mutant p53 Feedback Loop Promotes Oxaliplatin Resistance in Colorectal Cancer. | Mol Ther Nucleic Acids | 2020 | https://conductscience.org/library/papers/33251049 | PubMed |
| 6 | 26609479 | MicroRNA-320a inhibits proliferation and invasion of breast cancer cells by targeting RAB11A. | Am J Cancer Res | 2015 | https://conductscience.org/library/papers/26609479 | PubMed |
| 7 | 32548873 | lncRNA NR2F1-AS1 promotes breast cancer angiogenesis through activating IGF-1/IGF-1R/ERK pathway. | J Cell Mol Med | 2020 | https://conductscience.org/library/papers/32548873 | PubMed |
| 8 | 34218256 | A novel long non-coding RNA AC073352.1 promotes metastasis and angiogenesis via interacting with YBX1 in breast cancer. | Cell Death Dis | 2021 | https://conductscience.org/library/papers/34218256 | PubMed |
| 9 | 34429409 | Dysregulated cholesterol homeostasis results in resistance to ferroptosis increasing tumorigenicity and metastasis in cancer. | Nat Commun | 2021 | https://conductscience.org/library/papers/34429409 | PubMed |
| 10 | 32059473 | MAL2-Induced Actin-Based Protrusion Formation is Anti-Oncogenic in Hepatocellular Carcinoma. | Cancers (Basel) | 2020 | https://conductscience.org/library/papers/32059473 | PubMed |
| 11 | 32633366 | LINC00460 promotes proliferation and inhibits apoptosis of non-small cell lung cancer cells through targeted regulation of miR-539. | Eur Rev Med Pharmacol Sci | 2020 | https://conductscience.org/library/papers/32633366 | PubMed |
| 12 | 35405312 | Role of exosomal non-coding RNAs from tumor cells and tumor-associated macrophages in the tumor microenvironment. | Mol Ther | 2022 | https://conductscience.org/library/papers/35405312 | PubMed |
| 13 | 34445129 | The Role of lncRNA in the Development of Tumors, including Breast Cancer. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/34445129 | PubMed |
| 14 | 33271455 | FBW7-NRA41-SCD1 axis synchronously regulates apoptosis and ferroptosis in pancreatic cancer cells. | Redox Biol | 2021 | https://conductscience.org/library/papers/33271455 | PubMed |
| 15 | 23879588 | Cellular iron metabolism in prognosis and therapy of breast cancer. | Crit Rev Oncog | 2013 | https://conductscience.org/library/papers/23879588 | PubMed |
| 16 | 25736597 | MicroRNA-320a sensitizes tamoxifen-resistant breast cancer cells to tamoxifen by targeting ARPP-19 and ERRγ. | Sci Rep | 2015 | https://conductscience.org/library/papers/25736597 | PubMed |
| 17 | 33472555 | lncRNA LINC00460 Functions as a Competing Endogenous RNA and Regulates Expression of BGN by Sponging miR-149-5p in Colorectal Cancer. | Technol Cancer Res Treat | 2021 | https://conductscience.org/library/papers/33472555 | PubMed |
| 18 | 30195491 | MAL2 promotes proliferation, migration, and invasion through regulating epithelial-mesenchymal transition in breast cancer cell lines. | Biochem Biophys Res Commun | 2018 | https://conductscience.org/library/papers/30195491 | PubMed |
| 19 | 32990678 | MAL2 drives immune evasion in breast cancer by suppressing tumor antigen presentation. | J Clin Invest | 2021 | https://conductscience.org/library/papers/32990678 | PubMed |
| 20 | 34821482 | LncRNA LINC00460: Function and mechanism in human cancer. | Thorac Cancer | 2022 | https://conductscience.org/library/papers/34821482 | PubMed |
Cited by20
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 22 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42663506 | Inhibition of miR-301a-3p Expression Promotes Ferroptosis: A New Target for Ferroptosis Treatment in TNBC. | Breast J | 2026 | https://conductscience.org/library/papers/42663506 | PubMed |
| 42630874 | LINC00460 drives clear cell renal cell carcinoma progression via complement/coagulation and p53 pathways: a potential therapeutic target. | Am J Transl Res | 2026 | https://conductscience.org/library/papers/42630874 | PubMed |
| 42425938 | LINC01929 promotes breast cancer progression through a TFRC-associated ferroptosis pathway. | Cell Death Discov | 2026 | https://conductscience.org/library/papers/42425938 | PubMed |
| 41868675 | Epigenetic modifications in ferroptosis regulation of breast cancer. | Am J Cancer Res | 2026 | https://conductscience.org/library/papers/41868675 | PubMed |
| 41764215 | miR-320a enhances radiosensitivity in non-small cell lung cancer by targeting RAD51 and modulating ferroptosis via GPX4. | Sci Rep | 2026 | https://conductscience.org/library/papers/41764215 | PubMed |
| 41137040 | Long non-coding RNAs: key orchestrators of macrophage polarization in breast cancer. | Cancer Cell Int | 2025 | https://conductscience.org/library/papers/41137040 | PubMed |
| 41053050 | Targeting the redox-programmed cell death axis in breast cancer: from molecular mechanisms to therapeutic resistance. | Cell Death Discov | 2025 | https://conductscience.org/library/papers/41053050 | PubMed |
| 40887542 | Ferroptosis and non-coding RNAs in breast cancer: insights into CAF and TAM interactions. | Discov Oncol | 2025 | https://conductscience.org/library/papers/40887542 | PubMed |
| 40739681 | The Vital Role of Long Non-coding RNA SUMO1P3 in the Regulation of Human Cancer: Current Perspectives and Future Challenges. | Curr Top Med Chem | 2026 | https://conductscience.org/library/papers/40739681 | PubMed |
| 40176338 | Exploring Long Noncoding RNAs as Regulators of Tumor Ferroptosis: Advances and Challenges. | Cancer Sci | 2025 | https://conductscience.org/library/papers/40176338 | PubMed |
| 39763590 | The impact of ferroptosis and ferroptosis-related non-coding RNAs on breast cancer progression. | Front Cell Dev Biol | 2024 | https://conductscience.org/library/papers/39763590 | PubMed |
| 39759512 | The modulation of immune cell death in connection to microRNAs and natural products. | Front Immunol | 2024 | https://conductscience.org/library/papers/39759512 | PubMed |
| 39242964 | Non-coding transcriptome profiles in clear-cell renal cell carcinoma. | Nat Rev Urol | 2025 | https://conductscience.org/library/papers/39242964 | PubMed |
| 39022677 | Ferroptosis contributes to the progression of female-specific neoplasms, from breast cancer to gynecological malignancies in a manner regulated by non-coding RNAs: Mechanistic implications. | Noncoding RNA Res | 2024 | https://conductscience.org/library/papers/39022677 | PubMed |
| 38833042 | METTL3-modified lncRNA DSCAM-AS1 promotes breast cancer progression through inhibiting ferroptosis. | J Bioenerg Biomembr | 2024 | https://conductscience.org/library/papers/38833042 | PubMed |
| 38362940 | Research advances of MAL family members in tumorigenesis and tumor progression (Review). | Mol Med Rep | 2024 | https://conductscience.org/library/papers/38362940 | PubMed |
| 37920209 | Compounds targeting ferroptosis in breast cancer: progress and their therapeutic potential. | Front Pharmacol | 2023 | https://conductscience.org/library/papers/37920209 | PubMed |
| 37888204 | The Intergenic Type LncRNA (LINC RNA) Faces in Cancer with In Silico Scope and a Directed Lens to LINC00511: A Step toward ncRNA Precision. | Noncoding RNA | 2023 | https://conductscience.org/library/papers/37888204 | PubMed |
| 37686142 | The Regulation of Ferroptosis by Noncoding RNAs. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37686142 | PubMed |
| 37345137 | The MAL Family of Proteins: Normal Function, Expression in Cancer, and Potential Use as Cancer Biomarkers. | Cancers (Basel) | 2023 | https://conductscience.org/library/papers/37345137 | PubMed |
Genes30
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36938678
GET https://conductscience.org/api/papers/v1/36938678/references?page=2